Assyro AI

FDA Orange Book · active-ingredient family

Carvedilol

Carvedilol is approved as 1 brand and 17 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:COREG · NDA 020297

1

Brand (NDA)

17

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
COREGRLD×4WAYLIS THERAPNDA 020297ABMay 29, 1997

Generic (ANDA) products (17)

ProductApplicantApplicationTEApproved
CARVEDILOL×4MLVANDA 078786ABDec 22, 2009
CARVEDILOL×4PLIVA HRVATSKA DOOANDA 078240Oct 30, 2007
CARVEDILOL×4HIKMAANDA 077887Sep 07, 2007
CARVEDILOL×4AUROBINDO PHARMAANDA 078332ABSep 05, 2007
CARVEDILOL×4CHARTWELL MOLECULARANDA 077474ABSep 05, 2007
CARVEDILOL×4GLENMARK PHARMS LTDANDA 078251ABSep 05, 2007
CARVEDILOL×4LUPINANDA 078217Sep 05, 2007
CARVEDILOL×4PHARMOBEDIENTANDA 077316Sep 05, 2007
CARVEDILOL×4REGCON HOLDINGSANDA 078384ABSep 05, 2007
CARVEDILOL×4RISINGANDA 076649ABSep 05, 2007
CARVEDILOL×4RUBICON RESEARCHANDA 078165ABSep 05, 2007
CARVEDILOL×4SANDOZANDA 078227ABSep 05, 2007
CARVEDILOL×4SUN PHARM INDS INCANDA 077346Sep 05, 2007
CARVEDILOL×4SUN PHARM INDS LTDANDA 076989Sep 05, 2007
CARVEDILOL×4TAROANDA 077780Sep 05, 2007
CARVEDILOL×4TEVAANDA 076373ABSep 05, 2007
CARVEDILOL×4ZYDUS PHARMS USA INCANDA 077614ABSep 05, 2007

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Carvedilol — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.